Biofrontera AG - ADR
BFRA
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
$3.26
22.3% upside
Current Fair Value
22.3% upsideUndervalued by 22.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-4,915,000.00 |
| Dividend Yield | $0.13 (-) |
| Earnings per Share | $-0.47 |
| Beta | 1.55 |
| Outstanding Shares | 28,358,692 |
Return
| Return on Equity | -105.22% |
|---|---|
| Return on Assets | -24.16% |
| Return on Invested Capital | -31.55% |
Valuation & Multiples
| P/E Ratio | -0.91 |
|---|---|
| PEG | -21.42 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -0.18 |
| Enterprise Value to EBIT | 0.42 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -5.01 |
| Debt to Equity | 1.55 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Biofrontera AG
138 employees
CEO: Hermann Luebbert